MedPath

Atrial Fibrillation detection in OBESity using E-health

Completed
Conditions
obesitas
Atrial fibrillation in obesity
heart rhythm disturbance in severe overweight patients
10007521
Registration Number
NL-OMON56149
Lead Sponsor
Cardiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

BMI of >= 35 kg/m2 and scheduled for bariatric surgery, age >= 50 years and
written informed consent.

Exclusion Criteria

Known cardiac disease.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is the proportion of obesity patients with AF as<br /><br>detected by 1 week heart rhythm registration with an AF-detection patch (before<br /><br>bariatric surgery).<br /><br><br /><br>In 40 obesity patients with an increased CHA2DS2VASc-score who received both an<br /><br>AF-detection patch and an ILR, the proportions of patients with AF as detected<br /><br>by 1 week heart rhythm registration with the patch or 3 months with the ILR<br /><br>(before bariatric surgery) will also be explored. Results will be presented in<br /><br>a descriptive manner.<br /><br><br /><br>GLS (mean ± standard deviation) at baseline (before bariatric surgery) will be<br /><br>compared between obesity patients with versus without AF as identified by the<br /><br>AF-detection patch and/or ILR.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Change in the proportion of obesity patients with any AF episode as detected by<br /><br>an AF-detection patch between study onset (1 week monitoring before surgery)<br /><br>and one year after surgery (1 week monitoring).<br /><br><br /><br>Change in the proportion of obesity patients with any AF episode as detected by<br /><br>an ILR between study onset (3 months monitoring before surgery) and in the<br /><br>period of 9 to 12 months after surgery (3 months monitoring). </p><br>
© Copyright 2025. All Rights Reserved by MedPath